Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Venous Thrombosis

Free Subscription Articles published in Thromb Res Retrieve available abstracts of 265 articles: HTML format

Single Articles

March 2023
1. KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
   Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
   Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
   PubMed    
   
   
   
2. ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
   Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
   Thromb Res. 2023;225:28-32.
   PubMed     Abstract available
   
   
   February 2023
3. WIKLUND P, Medson K, Elf J
   Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
   Thromb Res. 2023;224:65-72.
   PubMed     Abstract available
   
   
   
4. PRANDONI P, Bilora F, Mahe I, Varona JF, et al
   The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
   Thromb Res. 2023;224:17-20.
   PubMed    
   
   
   
5. ROHATGI N, Dahlen A, Berube C, Weng Y, et al
   Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015-2019).
   Thromb Res. 2023;224:4-12.
   PubMed     Abstract available
   
   
   
6. ZHANG C, Deng Z, Yang Z, Xie J, et al
   A nomogram model to predict the acute venous thromboembolism risk after surgery in patients with glioma.
   Thromb Res. 2023;224:21-31.
   PubMed     Abstract available
   
   
   
7. VOSTATEK R, Hohensinner P, Nopp S, Haider P, et al
   Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism.
   Thromb Res. 2023;223:168-173.
   PubMed     Abstract available
   
   
   January 2023
8. MIRAMBEAUX R, Rodriguez C, Muriel A, Gonzalez S, et al
   Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism.
   Thromb Res. 2023;223:61-68.
   PubMed     Abstract available
   
   
   
9. ANDO K, Natsumeda M, Kawamura M, Shirakawa K, et al
   Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
   Thromb Res. 2023;223:36-43.
   PubMed     Abstract available
   
   
   
10. CIRES-DROUET R, LaRocco A, Soldin D, John T, et al
    Left ventricular systolic dysfunction during acute pulmonary embolism.
    Thromb Res. 2023;223:1-6.
    PubMed     Abstract available
    
    
    
11. OGUNSOLA AS, Farhadi K, Mercy UC, Elenwa F, et al
    Analysis of contemporary mortality trends in pulmonary embolism, United States, 1999-2020.
    Thromb Res. 2023;223:53-60.
    PubMed     Abstract available
    
    
    
12. KONG J, Hardwick A, Jiang SF, Sun K, et al
    CTEPH: A Kaiser Permanente Northern California Experience.
    Thromb Res. 2023;221:130-136.
    PubMed     Abstract available
    
    
    
13. ZHENG C, Ma J, Xu J, Wu L, et al
    The optimal regimen, efficacy and safety of tranexamic acid and aminocaproic acid to reduce bleeding for patients after total hip arthroplasty: A systematic review and Bayesian network meta-analysis.
    Thromb Res. 2023;221:120-129.
    PubMed     Abstract available
    
    
    December 2022
14. CHOPARD R, Campia U, Jering KS, Almarzooq ZI, et al
    Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center.
    Thromb Res. 2022;222:113-116.
    PubMed    
    
    
    
15. FISCHER S, Meisinger C, Linseisen J, Berghaus TM, et al
    Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors.
    Thromb Res. 2022;222:68-74.
    PubMed     Abstract available
    
    
    
16. MAXIMILIANO CL, Jaime GC, Erika MH
    Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban.
    Thromb Res. 2022;222:43-48.
    PubMed     Abstract available
    
    
    
17. YU JL, Lane M, Roach GD, Morrison SD, et al
    Perioperative venous thromboembolism risk considerations in the gender diverse patient - Should we consider more than just estrogen?
    Thromb Res. 2022;222:40-42.
    PubMed    
    
    
    
18. PRANDONI P, Gabara C, Bilora F, Aibar J, et al
    Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;222:16-19.
    PubMed    
    
    
    
19. HASSAN E, Motwani J
    Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism.
    Thromb Res. 2022;221:92-96.
    PubMed     Abstract available
    
    
    November 2022
20. IDING AFJ, Kremers BMM, Nagy M, Robles AP, et al
    Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
    Thromb Res. 2022;221:58-64.
    PubMed    
    
    
    
21. ARDESHIRROUHANIFARD S, Ellenbogen MI, Segal JB, Streiff MB, et al
    Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.
    Thromb Res. 2022;221:45-50.
    PubMed     Abstract available
    
    
    
22. ARDESHNA NS, Song M, Hyder SN, Grace KA, et al
    Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experience.
    Thromb Res. 2022;221:73-78.
    PubMed     Abstract available
    
    
    
23. TURPIE AGG, Farjat AE, Haas S, Ageno W, et al
    36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2022;222:31-39.
    PubMed     Abstract available
    
    
    
24. KAPTEIN FHJ, Stals MAM, Evenhuis RE, Gelderblom H, et al
    Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
    Thromb Res. 2022;221:19-25.
    PubMed     Abstract available
    
    
    
25. STEINER D, Nopp S, Weber B, Schlager O, et al
    The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study.
    Thromb Res. 2022;221:1-6.
    PubMed     Abstract available
    
    
    
26. KAPTEIJN MY, Kaptein FHJ, Stals MAM, Klaase EE, et al
    Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
    Thromb Res. 2022;221:10-18.
    PubMed     Abstract available
    
    
    
27. WYSOKINSKI WE, Houghton DE, Vlazny DT, Ashrani AA, et al
    Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
    Thromb Res. 2022;221:37-44.
    PubMed     Abstract available
    
    
    
28. BJORNHART B, Kristiansen C, Asmussen J, Hansen KH, et al
    Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
    Thromb Res. 2022 Nov 5. pii: S0049-3848(22)00438.
    PubMed     Abstract available
    
    
    October 2022
29. KNUEPPEL P, Bang SH, Troyer C, Barriga A, et al
    Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
    Thromb Res. 2022;220:91-96.
    PubMed     Abstract available
    
    
    
30. SILVEY M, Nguyen ATH, Amankwah EK, McElwaine E, et al
    Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium.
    Thromb Res. 2022;220:116-120.
    PubMed     Abstract available
    
    
    
31. WENGER N, Sebastian T, Beer JH, Mazzolai L, et al
    Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Res. 2022;220:65-71.
    PubMed     Abstract available
    
    
    
32. BAIDILDINOVA G, Ten Cate V, Nagler M, Panova-Noeva M, et al
    Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
    Thromb Res. 2022;220:75-87.
    PubMed     Abstract available
    
    
    
33. RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Abdel-Kader-Martin L, Otero-Candelera R, et al
    Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review.
    Thromb Res. 2022 Oct 11. pii: S0049-3848(22)00405.
    PubMed     Abstract available
    
    
    
34. MARTIN KA, Lyleroehr MJ, Cameron KA
    Barriers and facilitators to preventing venous thromboembolism in oncology practice.
    Thromb Res. 2022;220:21-23.
    PubMed    
    
    
    September 2022
35. GRIS JC, Bourguignon C, Bouvier S, Nouvellon E, et al
    Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.
    Thromb Res. 2022;219:102-108.
    PubMed     Abstract available
    
    
    
36. ALBLAS H, van Kan C, van Het Westeinde SC, Emmering J, et al
    Persistent dyspnea after acute pulmonary embolism is related to perfusion defects and lower long-term quality of life.
    Thromb Res. 2022;219:89-94.
    PubMed    
    
    
    
37. SPEKSNIJDER EM, Hessels LM, Muusses L, Buller HR, et al
    Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients.
    Thromb Res. 2022;219:109-111.
    PubMed    
    
    
    
38. KELLER K, Sivanathan V, Schmitt VH, Ostad MA, et al
    Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
    Thromb Res. 2022;219:77-85.
    PubMed     Abstract available
    
    
    
39. LUI B, Wee B, Lai J, Khattak Z, et al
    A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant - Has venous thromboembolism treatment become safer?
    Thromb Res. 2022;219:112-120.
    PubMed     Abstract available
    
    
    
40. YAMASHITA Y, Morimoto T, Kadota K, Takase T, et al
    Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.
    Thromb Res. 2022;219:30-39.
    PubMed     Abstract available
    
    
    
41. SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
    Educational differences in mortality but not in risk of recurrence following first-time pulmonary embolism: A Danish nationwide register-based study.
    Thromb Res. 2022;219:22-29.
    PubMed    
    
    
    
42. LOW SK, Anjum Z, Mahmoud A, Joshi U, et al
    Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
    Thromb Res. 2022;219:14-21.
    PubMed     Abstract available
    
    
    
43. BORST JM, Modi RN, Kirchberg TN, Box K, et al
    You're never too old for optimal venous thromboembolism prophylaxis: Re-thinking current trauma guidelines.
    Thromb Res. 2022;218:186-188.
    PubMed    
    
    
    August 2022
44. VOIGTLAENDER M, Edler C, Gerling M, Schadler J, et al
    Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.
    Thromb Res. 2022;218:171-176.
    PubMed     Abstract available
    
    
    
45. PRANDONI P, Bilora F, Pesavento R, Sancho T, et al
    The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;218:44-47.
    PubMed    
    
    
    
46. GORAN K
    Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis.
    Thromb Res. 2022;218:5-7.
    PubMed    
    
    
    
47. MESSI M, Beneyto Afonso C, Stalder O, Mean M, et al
    Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.
    Thromb Res. 2022;218:64-71.
    PubMed     Abstract available
    
    
    
48. WANG WD, Wei JP, Gao RQ, Yang QC, et al
    A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers.
    Thromb Res. 2022;216:52-58.
    PubMed     Abstract available
    
    
    
49. WIEGERS HMG, Scheres LJJ, Tahir L, Hutten BA, et al
    Risk of venous thromboembolism in women with endometriosis.
    Thromb Res. 2022;217:104-106.
    PubMed    
    
    
    July 2022
50. ATA F, Ibrahim WH, Choudry H, Shams A, et al
    Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2022;217:86-95.
    PubMed     Abstract available
    
    
    
51. CHOI SH, Nguyen H, Kanjwal S, Ibrahim I, et al
    COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data.
    Thromb Res. 2022;217:60-63.
    PubMed    
    
    
    
52. MAHARAJ S, Chang S, Kloecker G, Chesney J, et al
    Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
    Thromb Res. 2022;217:48-51.
    PubMed    
    
    
    
53. ZUIN M, Rigatelli G, Bilato C, Bongarzoni A, et al
    Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry.
    Thromb Res. 2022;217:15-21.
    PubMed    
    
    
    
54. PANCANI R, Villari L, Aquilini F, Palla A, et al
    Prognostic role of respiratory failure in acute pulmonary embolism: a prospective multicenter study.
    Thromb Res. 2022;217:33-35.
    PubMed    
    
    
    
55. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    PubMed     Abstract available
    
    
    June 2022
56. FANG MC, Go AS, Prasad PA, Zhou HX, et al
    Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Thromb Res. 2022;216:97-102.
    PubMed     Abstract available
    
    
    
57. SHIBAHASHI E, Jujo K, Kuroda S, Matsumoto S, et al
    Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
    Thromb Res. 2022;216:90-96.
    PubMed     Abstract available
    
    
    
58. VEETTIL SK, Harris J, Syeed MS, Thakkinstian A, et al
    Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
    Thromb Res. 2022;216:74-83.
    PubMed     Abstract available
    
    
    
59. SHEN J, Casie Chetty S, Shokouhi S, Maharjan J, et al
    Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients.
    Thromb Res. 2022;216:14-21.
    PubMed     Abstract available
    
    
    
60. GUMAN NAM, van Haaps TF, van Es N, Leeflang MMG, et al
    Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.
    Thromb Res. 2022;216:11-13.
    PubMed    
    
    
    May 2022
61. BRANDT W, Brown C, Wang TF, Tagalakis V, et al
    Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
    Thromb Res. 2022;216:8-10.
    PubMed     Abstract available
    
    
    
62. SUBHANI M, Sheth A, Ahmed J, Wijayasiri P, et al
    Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
    Thromb Res. 2022;215:19-29.
    PubMed     Abstract available
    
    
    
63. OBRADOVIC S, Subotic B, Dzudovic B, Matijasevic J, et al
    Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.
    Thromb Res. 2022;214:138-143.
    PubMed     Abstract available
    
    
    
64. BIKDELI B, Piazza G, Jimenez D, Muriel A, et al
    Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
    Thromb Res. 2022;214:122-131.
    PubMed     Abstract available
    
    
    
65. ROSA V, Chaar CIO, Espitia O, Otalora S, et al
    A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome.
    Thromb Res. 2022;213:65-70.
    PubMed     Abstract available
    
    
    
66. BARBERO E, Manas E, Bikdeli B, Garcia-Ortega A, et al
    Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2022;214:87-92.
    PubMed     Abstract available
    
    
    
67. MONREAL M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al
    TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
    Thromb Res. 2022;213 Suppl 2:S8-S9.
    PubMed     Abstract available
    
    
    
68. BOSCH FTM, Campello E, Henderson MW, Mulder FI, et al
    TEMPORARY REMOVAL: OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study.
    Thromb Res. 2022;213 Suppl 2:S4.
    PubMed     Abstract available
    
    
    
69. OVERVAD TF, Ording AG, Nielsen PB, Piazza G, et al
    TEMPORARY REMOVAL: OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors.
    Thromb Res. 2022;213 Suppl 2:S4-S5.
    PubMed     Abstract available
    
    
    
70. ANTONUCCI E, Barcella L, Russo L, Chistolini A, et al
    TEMPORARY REMOVAL: PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry.
    Thromb Res. 2022;213 Suppl 2:S39.
    PubMed     Abstract available
    
    
    
71. MARTIN AM, Lecumberri R, Souto JC, Aparicio J, et al
    TEMPORARY REMOVAL: PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients.
    Thromb Res. 2022;213 Suppl 2:S38-S39.
    PubMed     Abstract available
    
    
    
72. LOPEZ-NUNEZ JJ, Trujillo-Santos J, Bertoletti L, Lobo JL, et al
    TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study.
    Thromb Res. 2022;213 Suppl 2:S37-S38.
    PubMed     Abstract available
    
    
    
73. SALGADO M, Molina R, Vazquez EB, Martinez E, et al
    TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study.
    Thromb Res. 2022;213 Suppl 2:S36-S37.
    PubMed     Abstract available
    
    
    
74. DONADINI MP, Squizzato A, Ferrazzi P, Maggioni S, et al
    TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study.
    Thromb Res. 2022;213 Suppl 2:S30-S31.
    PubMed     Abstract available
    
    
    
75. ANIJS RJS, Chen Q, Lijfering WM, Cannegieter SC, et al
    TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis.
    Thromb Res. 2022;213 Suppl 2:S3.
    PubMed     Abstract available
    
    
    
76. HAQUE F, Jawad N, Brzuszek A, Birk R, et al
    TEMPORARY REMOVAL: PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients.
    Thromb Res. 2022;213 Suppl 2:S28.
    PubMed     Abstract available
    
    
    
77. FORESTA A, Colacioppo P, Baviera M, Ojeda-Fernandez L, et al
    TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
    Thromb Res. 2022;213 Suppl 2:S27-S28.
    PubMed     Abstract available
    
    
    
78. DAGUENET E, Maison M, Tinquaut F, Giroux EA, et al
    TEMPORARY REMOVAL: PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study.
    Thromb Res. 2022;213 Suppl 2:S21.
    PubMed     Abstract available
    
    
    
79. ALBERTSEN IE, Lyhne NM, Larsen TB, Nielsen PB, et al
    TEMPORARY REMOVAL: PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study.
    Thromb Res. 2022;213 Suppl 2:S21-S22.
    PubMed     Abstract available
    
    
    
80. MORAN LO, Pesantez D, Vazquez EB, Garay DF, et al
    TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer.
    Thromb Res. 2022;213 Suppl 2:S20.
    PubMed     Abstract available
    
    
    
81. GERVASO L, Laffi A, Meneses-Medina MI, Cella CA, et al
    TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms.
    Thromb Res. 2022;213 Suppl 2:S19-S20.
    PubMed     Abstract available
    
    
    
82. JORGENSEN H, Horvath-Puho E, Laugesen K, Braekkan S, et al
    TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism.
    Thromb Res. 2022;213 Suppl 2:S18-S19.
    PubMed     Abstract available
    
    
    
83. SILVA-CARDENAS DC, Pikabea-Diaz F, Zumarraga-Cuesta A, Lopez-Santillan M, et al
    TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients.
    Thromb Res. 2022;213 Suppl 2:S17.
    PubMed     Abstract available
    
    
    
84. CHARLES S, Chaudier A, Fatrara T, Daguenet E, et al
    TEMPORARY REMOVAL: PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma.
    Thromb Res. 2022;213 Suppl 2:S13.
    PubMed     Abstract available
    
    
    
85. TROELSEN FS, Vago EK, Horvath-Puho E, van Es N, et al
    TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study.
    Thromb Res. 2022;213 Suppl 2:S11.
    PubMed     Abstract available
    
    
    
86. JAKOBSEN SS, Frokjaer JB, Fisker RV, Kristensen SR, et al
    TEMPORARY REMOVAL: PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients.
    Thromb Res. 2022;213 Suppl 2:S11-S12.
    PubMed     Abstract available
    
    
    
87. RUIZ M, Martin AM, Font C, Castellon V, et al
    TEMPORARY REMOVAL: OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study.
    Thromb Res. 2022;213 Suppl 2:S1.
    PubMed     Abstract available
    
    
    
88. MCCRAE KR, Swaidani S, Diaz-Montero CM, Khorana AA, et al
    Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy.
    Thromb Res. 2022;213.
    PubMed     Abstract available
    
    
    
89. MOIK F, Ay C
    Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies.
    Thromb Res. 2022;213 Suppl 1:S58-S65.
    PubMed     Abstract available
    
    
    
90. DELLUC A, Robin P
    (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?
    Thromb Res. 2022;213 Suppl 1:S42-S45.
    PubMed     Abstract available
    
    
    
91. MANTHA S, Rak J
    Cancer genetic alterations and risk of venous thromboembolism.
    Thromb Res. 2022;213 Suppl 1:S29-S34.
    PubMed     Abstract available
    
    
    
92. SANFILIPPO KM
    Venous thromboembolism and risk stratification in hematological malignancies.
    Thromb Res. 2022;213 Suppl 1:S16-S21.
    PubMed     Abstract available
    
    
    April 2022
93. NOUMEGNI SR, Didier R, Mansourati V, Tromeur C, et al
    Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Thromb Res. 2022;214:93-105.
    PubMed     Abstract available
    
    
    
94. LIND MM, Johansson M, Sjalander A, Johansson L, et al
    Incidence and risk factors of venous thromboembolism in men and women.
    Thromb Res. 2022;214:82-86.
    PubMed     Abstract available
    
    
    
95. PORFIDIA A, Esposto G, Manzo C, Santini P, et al
    No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.
    Thromb Res. 2022;214:44-46.
    PubMed    
    
    
    
96. RUSSO F, Cianfanelli L, Chieffo A, Galli M, et al
    Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience.
    Thromb Res. 2022;214:40-43.
    PubMed    
    
    
    
97. CATELLA J, Bertoletti L, Moustafa F, Nieto JA, et al
    Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Thromb Res. 2022;214:29-36.
    PubMed     Abstract available
    
    
    March 2022
98. ROBERTS LN, Navaratnam AV, Arya R, Briggs TWR, et al
    Venous thromboembolism in patients hospitalised with COVID-19 in England.
    Thromb Res. 2022;213:138-144.
    PubMed     Abstract available
    
    
    
99. VAN DER VLEUTEN CJM, Zwerink LGJM, Klappe EM, de Jong EMGJ, et al
    Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?
    Thromb Res. 2022;213:30-33.
    PubMed    
    
    
    
100. BOVA C, Vigna E, Gentile M, Pignataro FS, et al
     Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis.
     Thromb Res. 2022;213:43-46.
     PubMed    
     
     
     
101. ABUFARHANEH M, Pandya RK, Alkhaja A, Iansavichene A, et al
     Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
     Thromb Res. 2022;213:47-56.
     PubMed     Abstract available
     
     
     
102. PALARETI G, Bignamini AA, Urbanek T, Cini M, et al
     Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
     Thromb Res. 2022;211:140-146.
     PubMed     Abstract available
     
     
     February 2022
103. ABRUZZO A, Gorantla V, Thomas SE
     Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review.
     Thromb Res. 2022;212:58-71.
     PubMed     Abstract available
     
     
     
104. CATELLA J, Joly M, Pernod G
     Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
     Thromb Res. 2022;213:8.
     PubMed    
     
     
     
105. VOCI D, Fedeli U, Farmakis IT, Hobohm L, et al
     Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.
     Thromb Res. 2022;212:44-50.
     PubMed     Abstract available
     
     
     
106. DANIELSBACKA JS, Mannerkorpi K, Olsen MF
     Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.
     Thromb Res. 2022;212:22-29.
     PubMed     Abstract available
     
     
     
107. BONNESEN K, Heide-Jorgensen U, Albertsen LW, Schmidt SAJ, et al
     Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism.
     Thromb Res. 2022;212:9-18.
     PubMed     Abstract available
     
     
     
108. TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
     Advances in treatment of chronic thromboembolic pulmonary hypertension.
     Thromb Res. 2022;212:30-37.
     PubMed     Abstract available
     
     
     
109. BEAUDOIN E, Kaka S, Gagnon E, Durivage A, et al
     Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study.
     Thromb Res. 2022;212:19-21.
     PubMed    
     
     
     
110. BETENSKY M, Kumar R, Hankins JS, Goldenberg NA, et al
     Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
     Thromb Res. 2022;211:133-139.
     PubMed     Abstract available
     
     
     
111. KALAITZOPOULOS DR, Panagopoulos A, Samant S, Ghalib N, et al
     Management of venous thromboembolism in pregnancy.
     Thromb Res. 2022;211:106-113.
     PubMed     Abstract available
     
     
     January 2022
112. KALAYCI A, Gibson CM, Hernandez AF, Hull RD, et al
     Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
     Thromb Res. 2022;211:63-69.
     PubMed     Abstract available
     
     
     
113. SHEN Y, Zhang Y, Xiong Y, Zhang Z, et al
     Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism.
     Thromb Res. 2022;211:49-55.
     PubMed     Abstract available
     
     
     
114. POHL KR, Hobohm L, Krieg VJ, Sentler C, et al
     Impact of thyroid dysfunction on short-term outcomes and long-term mortality in patients with pulmonary embolism.
     Thromb Res. 2022;211:70-78.
     PubMed     Abstract available
     
     
     
115. CABALLERO-ERASO C, Lopez-Ramirez C, Marin-Romero S, Carrera-Cueva C, et al
     Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study.
     Thromb Res. 2022;211:81-84.
     PubMed    
     
     
     
116. BIKDELI B, Moustafa F, Nieto JA, Lee AI, et al
     Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
     Thromb Res. 2022;211:10-18.
     PubMed     Abstract available
     
     
     December 2021
117. PETRELLI F, Cabiddu M, Borgonovo K, Parati MC, et al
     Osimertinib-related venous thromboembolism in non small lung cancer.
     Thromb Res. 2021;210:63-66.
     PubMed    
     
     
     
118. SIMARD C, Malhame I, Skeith L, Carson MP, et al
     Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.
     Thromb Res. 2021;210:20-25.
     PubMed     Abstract available
     
     
     
119. WANG L, Wei S, Zhou B, Wu S, et al
     Corrigendum to "A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors" [Thromb. Res. 202, June 2021, 52-58].
     Thromb Res. 2021;210:4-5.
     PubMed    
     
     
     
120. SONNE-HOLM E, Kjaergaard J, Bang LE, Fosbol E, et al
     Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999-2018.
     Thromb Res. 2021;210:12-19.
     PubMed     Abstract available
     
     
     
121. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
     Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
     Thromb Res. 2021;209:105.
     PubMed    
     
     
     
122. ZUIN M, Engelen MM, Barco S, Spyropoulos AC, et al
     Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.
     Thromb Res. 2021;209:94-98.
     PubMed    
     
     
     
123. DE WINTER MA, Timmers T, Hovens MMC, Iglesias Del Sol A, et al
     Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial.
     Thromb Res. 2021;209:86-93.
     PubMed     Abstract available
     
     
     
124. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
     Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
     Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545.
     PubMed    
     
     
     November 2021
125. VERMA AA, Masoom H, Pou-Prom C, Shin S, et al
     Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients.
     Thromb Res. 2021;209:51-58.
     PubMed     Abstract available
     
     
     
126. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
     Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
     Thromb Res. 2021;208:190-197.
     PubMed     Abstract available
     
     
     
127. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
     Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
     Thromb Res. 2021;208:170-172.
     PubMed    
     
     
     
128. GIRAUD M, Catella J, Cognet L, Helfer H, et al
     Management of acute venous thromboembolism in patients taking antiplatelet therapy.
     Thromb Res. 2021;208:156-161.
     PubMed     Abstract available
     
     
     
129. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
     Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
     Thromb Res. 2021;208:106-111.
     PubMed     Abstract available
     
     
     
130. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
     Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
     Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
     PubMed    
     
     
     October 2021
131. LEE A, Oley F Jr, Lo M, Fong R, et al
     Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
     Thromb Res. 2021;208:148-155.
     PubMed     Abstract available
     
     
     
132. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
     Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
     Thromb Res. 2021;208:79-82.
     PubMed     Abstract available
     
     
     
133. HILL H, Robinson M, Lu L, Slaughter D, et al
     Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
     Thromb Res. 2021;208:71-78.
     PubMed     Abstract available
     
     
     
134. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
     Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
     Thromb Res. 2021;208:121-126.
     PubMed     Abstract available
     
     
     
135. LI A, Brandt W, Brown C, Wang TF, et al
     Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
     Thromb Res. 2021;208:58-65.
     PubMed     Abstract available
     
     
     
136. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
     Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
     Thromb Res. 2021;208:52-57.
     PubMed     Abstract available
     
     
     
137. LI J, Yi J, Hua L, Su Y, et al
     Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
     Thromb Res. 2021;208:45-51.
     PubMed     Abstract available
     
     
     
138. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
     Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
     Thromb Res. 2021;208:39-44.
     PubMed     Abstract available
     
     
     
139. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
     Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
     Thromb Res. 2021;208:4-10.
     PubMed     Abstract available
     
     
     
140. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
     Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
     Thromb Res. 2021;207:150-157.
     PubMed     Abstract available
     
     
     
141. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
     Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
     Thromb Res. 2021;206:66-75.
     PubMed     Abstract available
     
     
     September 2021
142. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
     Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
     Thromb Res. 2021;207:143-149.
     PubMed     Abstract available
     
     
     
143. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
     Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
     Thromb Res. 2021;207:113-115.
     PubMed    
     
     
     
144. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
     Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
     Thromb Res. 2021;207:116-122.
     PubMed     Abstract available
     
     
     
145. GABET A, Grave C, Tuppin P, Emmerich J, et al
     Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
     Thromb Res. 2021;207:67-74.
     PubMed     Abstract available
     
     
     
146. OHASHI Y, Ikeda M, Kunitoh H, Sasako M, et al
     One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
     Thromb Res. 2021 Sep 21. pii: S0049-3848(21)00464.
     PubMed     Abstract available
     
     
     
147. OAKES M, Arastu A, Kato C, Somers J, et al
     Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
     Thromb Res. 2021;207:96-98.
     PubMed     Abstract available
     
     
     August 2021
148. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
     Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
     Thromb Res. 2021;206:139-141.
     PubMed    
     
     
     
149. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
     Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
     Thromb Res. 2021;206:128-130.
     PubMed    
     
     
     
150. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
     Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
     Thromb Res. 2021;206:99-103.
     PubMed     Abstract available
     
     
     
151. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
     Pulmonary embolism and deep vein thrombosis: Similar but different.
     Thromb Res. 2021;206:88-98.
     PubMed     Abstract available
     
     
     
152. JOHNSON SA, Jones AE, Young E, Jennings C, et al
     A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
     Thromb Res. 2021;206:120-127.
     PubMed     Abstract available
     
     
     
153. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
     Media portrayals of pulmonary embolism.
     Thromb Res. 2021;206:52-54.
     PubMed    
     
     
     
154. FILIPPI L, Sartori M, Facci M, Trentin M, et al
     Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
     Thromb Res. 2021;206:29-32.
     PubMed     Abstract available
     
     
     
155. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
     Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
     Thromb Res. 2021;207:134-139.
     PubMed     Abstract available
     
     
     
156. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
     Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
     Thromb Res. 2021;204:114-122.
     PubMed     Abstract available
     
     
     July 2021
157. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
     Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
     Thromb Res. 2021;206:36-41.
     PubMed     Abstract available
     
     
     
158. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
     Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
     Thromb Res. 2021;205:63-69.
     PubMed     Abstract available
     
     
     
159. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
     "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
     Thromb Res. 2021;205:56-62.
     PubMed     Abstract available
     
     
     
160. LACHANT D, Roto D, Rappaport S, Prasad P, et al
     Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
     Thromb Res. 2021;205:40-43.
     PubMed    
     
     
     
161. METRA B, Summer R, Brooks SE, George G, et al
     Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
     Thromb Res. 2021;205:84-91.
     PubMed     Abstract available
     
     
     
162. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
     Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
     Thromb Res. 2021;205:11-16.
     PubMed     Abstract available
     
     
     
163. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
     Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
     Thromb Res. 2021;206:1-4.
     PubMed    
     
     
     
164. RIGATELLI G, Zuin M
     Not all patent foramen ovales are alike!
     Thromb Res. 2021;203:81.
     PubMed    
     
     
     
165. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
     Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
     Thromb Res. 2021;205:17-23.
     PubMed     Abstract available
     
     
     June 2021
166. JIN MC, Sussman ES, Feng AY, Han SS, et al
     Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
     Thromb Res. 2021;204:126-133.
     PubMed     Abstract available
     
     
     
167. RIVERA-LEBRON B, Bauersachs R
     Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
     Thromb Res. 2021;204:101-107.
     PubMed     Abstract available
     
     
     
168. KO D, Preis SR, Johnson AD, Vasan RS, et al
     Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
     Thromb Res. 2021;204:108-113.
     PubMed     Abstract available
     
     
     
169. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
     S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
     Thromb Res. 2021;204:81-87.
     PubMed     Abstract available
     
     
     
170. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
     Difference between Japanese and White patients with acute pulmonary embolism.
     Thromb Res. 2021;204:52-56.
     PubMed    
     
     
     
171. BAN L, Abdul Sultan A, West J, Tata LJ, et al
     External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
     Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
     PubMed     Abstract available
     
     
     
172. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
     Management of high-risk pulmonary embolism in pregnancy.
     Thromb Res. 2021;204:57-65.
     PubMed     Abstract available
     
     
     
173. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
     Cancer risk after a venous thrombotic event - RIETE score.
     Thromb Res. 2021;202:43-44.
     PubMed    
     
     
     
174. VALERIO L, Corsi G, Granziera S, Holm K, et al
     Sex differences in Lemierre syndrome: Individual patient-level analysis.
     Thromb Res. 2021;202:36-39.
     PubMed    
     
     
     May 2021
175. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
     Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
     Thromb Res. 2021;204:9-12.
     PubMed     Abstract available
     
     
     
176. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
     Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
     Thromb Res. 2021;204:29-31.
     PubMed    
     
     
     
177. LE MAO R, Tromeur C, Couturaud F
     A case of acute pulmonary embolism with severe haemoptysis.
     Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
     PubMed     Abstract available
     
     
     
178. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
     Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
     Thromb Res. 2021;203:172-185.
     PubMed     Abstract available
     
     
     
179. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
     The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
     Thromb Res. 2021;203:155-162.
     PubMed     Abstract available
     
     
     
180. BARATH B, Bogati R, Miklos T, Kallai J, et al
     Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
     Thromb Res. 2021;203:110-116.
     PubMed     Abstract available
     
     
     
181. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
     Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
     Thromb Res. 2021;203:93-100.
     PubMed     Abstract available
     
     
     
182. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
     A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
     Thromb Res. 2021;203:190-195.
     PubMed     Abstract available
     
     
     
183. MUMOLI N, Conte G, Cei M, Vitale J, et al
     In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
     Thromb Res. 2021;203:82-84.
     PubMed    
     
     
     
184. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
     Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
     Thromb Res. 2021;203:74-80.
     PubMed     Abstract available
     
     
     
185. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
     Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
     Thromb Res. 2021;201:18-22.
     PubMed     Abstract available
     
     
     April 2021
186. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
     Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
     Thromb Res. 2021;202:155-161.
     PubMed     Abstract available
     
     
     
187. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
     Pulmonary infarction in acute pulmonary embolism.
     Thromb Res. 2021;202:162-169.
     PubMed     Abstract available
     
     
     
188. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
     Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
     Thromb Res. 2021;202:145-147.
     PubMed    
     
     
     March 2021
189. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
     Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
     Thromb Res. 2021;202:128-133.
     PubMed     Abstract available
     
     
     
190. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
     Lifestyle factors and venous thromboembolism in two cohort studies.
     Thromb Res. 2021;202:119-124.
     PubMed     Abstract available
     
     
     
191. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
     Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
     Thromb Res. 2021;202:105-107.
     PubMed    
     
     
     
192. SKEITH L, Le Gal G, Rodger MA
     Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
     Thromb Res. 2021;202:134-138.
     PubMed     Abstract available
     
     
     
193. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
     COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
     Thromb Res. 2021;202:77-83.
     PubMed     Abstract available
     
     
     
194. ALLEN S, Chan L, Masic D, Porcaro K, et al
     Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
     Thromb Res. 2021;202:96-99.
     PubMed    
     
     
     
195. PETRELLI F, Solinas C
     Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
     Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
     PubMed    
     
     
     
196. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
     Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
     Thromb Res. 2021;202:17-23.
     PubMed     Abstract available
     
     
     
197. LACUT K, Le Moigne E, Couturaud F, Font C, et al
     Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
     Thromb Res. 2021;202:59-66.
     PubMed     Abstract available
     
     
     
198. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
     A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
     Thromb Res. 2021;202:31-35.
     PubMed     Abstract available
     
     
     
199. FRERE C, Ederhy S, Salem JE
     Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
     Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
     PubMed    
     
     
     
200. WANG L, Wei S, Zhou B, Wu S, et al
     A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
     Thromb Res. 2021;202:52-58.
     PubMed     Abstract available
     
     
     
201. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
     Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
     Thromb Res. 2021;199:143-148.
     PubMed     Abstract available
     
     
     
202. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
     The effect of race on composite thrombotic events in patients with COVID-19.
     Thromb Res. 2021;199:10-13.
     PubMed     Abstract available
     
     
     February 2021
203. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
     Three-month follow-up of pulmonary embolism in patients with COVID-19.
     Thromb Res. 2021;201:113-115.
     PubMed    
     
     
     
204. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
     Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
     Thromb Res. 2021;201:131-138.
     PubMed     Abstract available
     
     
     
205. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
     Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
     Thromb Res. 2021;201:63-72.
     PubMed     Abstract available
     
     
     
206. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
     Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
     Thromb Res. 2021;201:90-99.
     PubMed     Abstract available
     
     
     
207. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
     Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
     Thromb Res. 2021;201:1-5.
     PubMed     Abstract available
     
     
     
208. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
     An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
     Thromb Res. 2021;200:99-101.
     PubMed    
     
     
     
209. 
     Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
     Thromb Res. 2021;200:130-132.
     PubMed    
     
     
     January 2021
210. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
     Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
     Thromb Res. 2021;200:48-50.
     PubMed    
     
     
     
211. BECATTINI C, Cimini LA, Carrier M
     Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
     Thromb Res. 2021;200:41-47.
     PubMed     Abstract available
     
     
     
212. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
     Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
     Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
     PubMed    
     
     
     
213. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
     Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
     Thromb Res. 2021;199:101-105.
     PubMed     Abstract available
     
     
     
214. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
     Venous-thromboembolism in elderly patients with acute myeloid leukemia.
     Thromb Res. 2021;200:9-11.
     PubMed    
     
     
     
215. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
     Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
     Thromb Res. 2021;200:23-29.
     PubMed     Abstract available
     
     
     
216. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
     Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
     Thromb Res. 2021;199:85-96.
     PubMed     Abstract available
     
     
     
217. MURGIER M, Fouillet L, Ollier E, Merah A, et al
     Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
     Thromb Res. 2021;199:106-109.
     PubMed    
     
     
     
218. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
     Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
     Thromb Res. 2021;199:97-100.
     PubMed    
     
     
     
219. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
     Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
     Thromb Res. 2021;199:123-131.
     PubMed     Abstract available
     
     
     
220. MOIK F, Makatsariya A, Ay C
     Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
     Thromb Res. 2021;199:38-42.
     PubMed     Abstract available
     
     
     
221. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
     In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
     Thromb Res. 2021;197:112-113.
     PubMed    
     
     
     
222. PANCANI R, Villari L, Foci V, Parri G, et al
     Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
     Thromb Res. 2021;197:44-47.
     PubMed     Abstract available
     
     
     December 2020
223. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
     Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
     Thromb Res. 2020;199:14-18.
     PubMed     Abstract available
     
     
     
224. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
     Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
     Thromb Res. 2020;199:59-66.
     PubMed     Abstract available
     
     
     
225. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
     Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
     Thromb Res. 2020;199:82-84.
     PubMed    
     
     
     
226. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
     Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
     Thromb Res. 2020;199:32-34.
     PubMed    
     
     
     
227. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
     Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
     Thromb Res. 2020;198:135-138.
     PubMed     Abstract available
     
     
     
228. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
     Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
     Thromb Res. 2020;198:163-170.
     PubMed     Abstract available
     
     
     
229. DE WIT K, Linkins LA
     A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
     Thromb Res. 2020;198:83-85.
     PubMed     Abstract available
     
     
     
230. MIAO R, Dong X, Gong J, Wang Y, et al
     Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
     Thromb Res. 2020;198:122-131.
     PubMed     Abstract available
     
     
     
231. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
     Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2020;198:103-114.
     PubMed     Abstract available
     
     
     
232. WANG L, Chen F, Bai L, Yi Q, et al
     In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
     Thromb Res. 2020;196:541-542.
     PubMed    
     
     
     
233. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
     COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
     Thromb Res. 2020;196:355-358.
     PubMed     Abstract available
     
     
     November 2020
234. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
     Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
     Thromb Res. 2020;198:26-33.
     PubMed     Abstract available
     
     
     
235. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
     Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
     Thromb Res. 2020;198:1-6.
     PubMed     Abstract available
     
     
     
236. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
     Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
     Thromb Res. 2020;198:52-54.
     PubMed    
     
     
     
237. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
     Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
     Thromb Res. 2020;198:34-39.
     PubMed     Abstract available
     
     
     
238. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
     D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
     Thromb Res. 2020;197:160-164.
     PubMed     Abstract available
     
     
     
239. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
     Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
     Thromb Res. 2020;197:144-152.
     PubMed     Abstract available
     
     
     
240. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
     Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
     Thromb Res. 2020;197:94-99.
     PubMed     Abstract available
     
     
     
241. ROBERGE G, Delluc A
     Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
     Thromb Res. 2020;197:77-83.
     PubMed     Abstract available
     
     
     
242. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
     Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
     Thromb Res. 2020;197:48-55.
     PubMed     Abstract available
     
     
     
243. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
     Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
     Thromb Res. 2020;197:8-12.
     PubMed     Abstract available
     
     
     
244. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
     The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
     Thromb Res. 2020;195:228-230.
     PubMed    
     
     
     
245. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
     Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
     Thromb Res. 2020;198:40-48.
     PubMed     Abstract available
     
     
     October 2020
246. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
     Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
     Thromb Res. 2020;196:539-540.
     PubMed    
     
     
     
247. SPEED V, Patel JP, Roberts LN, Patel RK, et al
     UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
     Thromb Res. 2020;197:16-19.
     PubMed    
     
     
     
248. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
     The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
     Thromb Res. 2020;196:486-490.
     PubMed     Abstract available
     
     
     
249. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
     Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
     Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
     PubMed    
     
     
     
250. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
     More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
     Thromb Res. 2020;196:435-436.
     PubMed    
     
     
     
251. HAN X, Li C, Zhang S, Hou X, et al
     Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
     Thromb Res. 2020;196:500-509.
     PubMed     Abstract available
     
     
     
252. VALERIO L, Corsi G, Sebastian T, Barco S, et al
     Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
     Thromb Res. 2020;196:494-499.
     PubMed     Abstract available
     
     
     
253. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
     Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
     Thromb Res. 2020;196:476-482.
     PubMed     Abstract available
     
     
     
254. GERSTEIN L, Koolian M, Schwartz BC
     Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
     Thromb Res. 2020;196:463-465.
     PubMed    
     
     
     
255. DOYLE AJ, Thomas W, Retter A, Besser M, et al
     Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
     Thromb Res. 2020;196:454-456.
     PubMed    
     
     
     
256. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
     Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
     Thromb Res. 2020;196:444-453.
     PubMed     Abstract available
     
     
     
257. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
     Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
     Thromb Res. 2020;194:220-221.
     PubMed    
     
     
     September 2020
258. YANG M, Qi J, Tang Y, Wu D, et al
     Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2020;196:410-413.
     PubMed    
     
     
     
259. MA SG, Hu J, Huang Y
     The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
     Thromb Res. 2020;196:325-334.
     PubMed     Abstract available
     
     
     
260. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
     D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
     Thromb Res. 2020;196:318-321.
     PubMed    
     
     
     
261. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
     High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
     Thromb Res. 2020;196:349-354.
     PubMed     Abstract available
     
     
     
262. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
     Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
     Thromb Res. 2020;196:308-312.
     PubMed     Abstract available
     
     
     
263. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
     Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
     Thromb Res. 2020;196:313-317.
     PubMed     Abstract available
     
     
     
264. DELATE T, Charlu M, Zhu S, Pai A, et al
     Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
     Thromb Res. 2020;196:367-370.
     PubMed     Abstract available
     
     
     
265. MIRO O, Llorens P, Aguirre A, Lozano L, et al
     Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
     Thromb Res. 2020;196:322-324.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: